Home / Lidocaine / United States
US ATC C01BB01 · updated 2 Nov 2026
Lidocaine shortage in United States
Is there a Lidocaine shortage in United States?
Yes. As of 2 Nov 2026, 49 Lidocaine products are reported short in United States, the first since 22 Feb 2012. No return date has been given. Main reason: not stated.
Also short in Canada. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Lidocaine Hydochloride, Injection, 50 mg/5 mL (NDC 83634-653-05) | Anthea Pharma | 22 Feb 2012 | not given | Not stated |
| US | Lidocaine Hydrochloride In Plastic Container, Injection, 10 mg/1 mL (NDC 63323-201-02) | Fresenius Kabi USA, LLC | 22 Feb 2012 | not given | Not stated |
| US | Lidocaine Hydrochloride Preservative Free In Plastic Container, Injection, 100 mg/5mL (2%,20 mg/1 mL) Syringes (NDC 0409-1323-05) limited | Hospira, Inc., a Pfizer Company | 22 Feb 2012 | not given | Other |
| US | Lidocaine Hydrochloride Preservative Free In Plastic Container, Injection, 50 mg/5mL (1%, 10 mg/1 mL) Syringes (NDC 0409-9137-05) | Hospira, Inc., a Pfizer Company | 22 Feb 2012 | not given | Not stated |
| US | Lidocaine Hydrochloride Preservative Free, Injection, 20 mg/1 mL (NDC 63323-208-05) | Fresenius Kabi USA, LLC | 22 Feb 2012 | not given | Increased demand Demand increase for the drug |
| US | Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 63323-201-10) | Fresenius Kabi USA, LLC | 22 Feb 2012 | not given | Increased demand Demand increase for the drug |
| US | Lidocaine Hydrochloride, Injection, 100 mg/10 mL (NDC 83634-651-10) | Anthea Pharma | 22 Feb 2012 | not given | Not stated |
| US | Lidocaine Hydrochloride, Injection, 100 mg/5 mL (2%; 20 mg/mL) (NDC 0409-2066-05) | Hospira, Inc., a Pfizer Company | 22 Feb 2012 | not given | Not stated |
| US | Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 63323-202-02) | Fresenius Kabi USA, LLC | 22 Feb 2012 | not given | Not stated |
| US | Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 76329-3390-1) | Amphastar Pharmaceuticals, Inc. | 22 Feb 2012 | not given | Not stated |
| US | Lidocaine Hydrochloride, Injection, 20 mg/2 mL (NDC 83634-653-02) | Anthea Pharma | 22 Feb 2012 | not given | Not stated |
| US | Lidocaine Hydrochloride, Injection, 200 mg/20 mL (NDC 83634-651-20) | Anthea Pharma | 22 Feb 2012 | not given | Not stated |
| US | Lidocaine Hydrochloride, Injection, 300 mg/30 mL (NDC 83634-653-30) | Anthea Pharma | 22 Feb 2012 | not given | Not stated |
| US | Lidocaine Hydrochloride, Injection, 500 mg/50 mL (NDC 83634-651-50) | Anthea Pharma | 22 Feb 2012 | not given | Not stated |
| US | Xylocaine, Injection, 10 mg/1 mL (NDC 63323-485-27) | Fresenius Kabi USA, LLC | 22 Feb 2012 | not given | Not stated |
| US | Xylocaine, Injection, 10 mg/1 mL (NDC 63323-485-57) | Fresenius Kabi USA, LLC | 22 Feb 2012 | not given | Increased demand Demand increase for the drug |
| US | Xylocaine, Injection, 10 mg/1 mL (NDC 63323-492-27) | Fresenius Kabi USA, LLC | 22 Feb 2012 | not given | Not stated |
| US | Xylocaine, Injection, 10 mg/1 mL (NDC 63323-492-31) | Fresenius Kabi USA, LLC | 22 Feb 2012 | not given | Increased demand Demand increase for the drug |
| US | Xylocaine, Injection, 10 mg/1 mL (NDC 63323-492-37) | Fresenius Kabi USA, LLC | 22 Feb 2012 | not given | Not stated |
| US | Xylocaine, Injection, 10 mg/1 mL (NDC 63323-492-57) | Fresenius Kabi USA, LLC | 22 Feb 2012 | not given | Not stated |
| US | Xylocaine, Injection, 15 mg/1 mL (NDC 63323-493-91) | Fresenius Kabi USA, LLC | 22 Feb 2012 | not given | Increased demand Demand increase for the drug |
| US | Xylocaine, Injection, 15 mg/1 mL (NDC 63323-493-97) | Fresenius Kabi USA, LLC | 22 Feb 2012 | not given | Increased demand Demand increase for the drug |
| US | Xylocaine, Injection, 20 mg/1 mL (NDC 63323-486-17) | Fresenius Kabi USA, LLC | 22 Feb 2012 | not given | Not stated |
| US | Xylocaine, Injection, 20 mg/1 mL (NDC 63323-486-27) | Fresenius Kabi USA, LLC | 22 Feb 2012 | not given | Not stated |
| US | Xylocaine, Injection, 20 mg/1 mL (NDC 63323-486-57) | Fresenius Kabi USA, LLC | 22 Feb 2012 | not given | Other |
| US | Xylocaine, Injection, 20 mg/1 mL (NDC 63323-495-07) | Fresenius Kabi USA, LLC | 22 Feb 2012 | not given | Not stated |
| US | Xylocaine, Injection, 20 mg/1 mL (NDC 63323-495-27) | Fresenius Kabi USA, LLC | 22 Feb 2012 | not given | Not stated |
| US | Xylocaine, Injection, 20 mg/1 mL (NDC 63323-496-97) | Fresenius Kabi USA, LLC | 22 Feb 2012 | not given | Increased demand Demand increase for the drug |
| US | Xylocaine, Injection, 5 mg/1 mL (NDC 63323-484-57) | Fresenius Kabi USA, LLC | 22 Feb 2012 | not given | Increased demand Demand increase for the drug |
| US | Xylocaine, Injection, 5 mg/1 mL (NDC 63323-491-57) | Fresenius Kabi USA, LLC | 22 Feb 2012 | not given | Not stated |
| US | Lidocaine Hydrochloride And Dextrose, Injection, 4 mg/1 mL (NDC 0338-0409-03) | Baxter Healthcare | 25 Oct 2017 | not given | Not stated |
| US | Lidocaine Hydrochloride And Dextrose, Injection, 8 mg/1 mL (NDC 0338-0411-02) | Baxter Healthcare | 25 Oct 2017 | not given | Not stated |
| US | Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-159-74) | Eugia US LLC | 20 Feb 2018 | not given | Increased demand Demand increase for the drug |
| US | Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-161-02) | Eugia US LLC | 20 Feb 2018 | not given | Not stated |
| US | Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-162-05) | Eugia US LLC | 20 Feb 2018 | not given | Not stated |
| US | Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-163-30) | Eugia US LLC | 20 Feb 2018 | not given | Not stated |
| US | Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 55150-165-05) | Eugia US LLC | 20 Feb 2018 | not given | Increased demand Demand increase for the drug |
| US | Lidocaine Hydrochloride, Injection, 20 mg/mL (NDC 55150-164-02) | Eugia US LLC | 20 Feb 2018 | not given | Not stated |
| US | Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 0143-9577-10) | Hikma Pharmaceuticals USA, Inc. | 13 Jun 2018 | not given | Not stated |
| US | Lidocaine Hydrochloride, Injection, 10 mg/mL (NDC 55150-251-10) | Eugia US LLC | 13 Jun 2018 | not given | Not stated |
| US | Lidocaine Hydrochloride, Injection, 10 mg/mL (NDC 55150-252-20) | Eugia US LLC | 13 Jun 2018 | not given | Increased demand Demand increase for the drug |
| US | Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 0143-9575-10) | Hikma Pharmaceuticals USA, Inc. | 13 Jun 2018 | not given | Not stated |
| US | Lidocaine Hydrochloride, Injection, 20 mg/mL (NDC 55150-254-10) | Eugia US LLC | 13 Jun 2018 | not given | Increased demand Demand increase for the drug |
| US | Lidocaine Hydrochloride, Injection, 20 mg/mL (NDC 55150-255-20) | Eugia US LLC | 13 Jun 2018 | not given | Not stated |
| US | Lidocaine Hydrochloride, Injection, 20 mg/mL (NDC 55150-256-50) | Eugia US LLC | 13 Jun 2018 | not given | Increased demand Demand increase for the drug |
| US | Lidocaine Hydrochloride, Preservative Free, Injection, 10 mg/1 mL (NDC 0143-9595-25) | Hikma Pharmaceuticals USA, Inc. | 13 Jun 2018 | not given | Increased demand Demand increase for the drug |
| US | Lidocaine Hydrochloride, Preservative Free, Injection, 20 mg/1 mL (NDC 0143-9594-25) | Hikma Pharmaceuticals USA, Inc. | 13 Jun 2018 | not given | Not stated |
| US | Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 65282-1605-1) | Spectra Medical Devices, LLC | 14 Jun 2018 | not given | Other |
| US | Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 73293-0001-2) | Huons Co., Ltd. (South Korea) | 14 Jul 2018 | not given | Increased demand Demand increase for the drug |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).